Model for individual substitution of immunoglobulins after membrane plasma separation.
Patients who undergo extensive plasma exchanges using albumin replacement may be more susceptible to infection because they develop significant hypogammaglobulinemia. Substitution of IgG in these patients could be beneficial. A model to calculate the individual amount of IgG required is described. The course of IgG during chronic intermittent membrane plasma separation (MPS) therapy was simulated using an one-pool model. Three modes of substitution were considered for their efficacy: infusion after MPS infusion after discarding an equivalent plasma quantity after termination of MPS, and plasma exchange at the end of MPS against an IgG solution. Mode B was shown to be most economical and was subsequently used to check the validity of the substitution model in a prospective test. The difference between predicted and measured IgG levels was 5% both for simulations from one MPS to the next and for the long-term prediction. The data prove that replacement of IgG after plasma separation is practicable. The substitution model allows to fix in advance any plasma limit value for indication and target of the substitution therapy. Thus it permits to give therapeutic recommendations for individual IgG substitution therapy of secondary antibody deficiency after MPS.
D004406:Dysgammaglobulinemia / Q000517:prevention & control; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000276:immunology / Q000628:therapy; D017099:IgG Deficiency; D007074:Immunoglobulin G / Q000008:administration & dosage*; D008433:Mathematics; D008875:Middle Aged; D008954:Models, Biological; D010951:Plasma Exchange / Q000379:methods; D011446:Prospective Studies; D013997:Time Factors
D007074:Immunoglobulin G